Is Trillium Therapeutics Inc. (TRIL) A Good Stock To Buy?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money ...
Posts Tagged ‘NASDAQ:TRIL’
Hedge Funds Are Selling Trillium Therapeutics Inc. (TRIL)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Is TRIL Stock A Buy or Sell?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is TRIL A Good Stock To Buy According To Hedge Funds?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Hedge Funds Are Crazy About Trillium Therapeutics Inc. (TRIL)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Did Hedge Funds Make The Right Call On Trillium Therapeutics Inc. (TRIL) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Have Never Been This Bullish On Trillium Therapeutics Inc. (TRIL)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Trillium Therapeutics Inc. (NASDAQ:TRIL): Are Hedge Funds Right About This Stock?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
13G Filing: Matrix Capital Management and Trillium Therapeutics Inc (TRIL)
Please follow Matrix Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Matrix Capital Management or update...
13G Filing: Cormorant Asset Management and Trillium Therapeutics Inc. (TRIL)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent...
How Trillium Therapeutics Inc. (TRIL) Stacks Up Against Its Peers?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous ...
Breaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More
Steve Cohen's Point72 Asset Management has upped its stake in two companies and added two new holdings to its equity portfolio, according to four separate Schedule 13G forms ...
Ridgeback Capital’s Latest Healthcare Picks: Cara Therapeutics, Trillium Therapeutics and More
Incorporated in 2006, Ridgeback Capital was founded by Wayne Holman, with a major focus on the healthcare sector.
Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector
At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with the Securities and Exchange...
